THE UK National Institute for Health and Care Excellence (NICE) has recommended that cancer patients in the UK have access to three blood cancer drugs, brentuximab vedotin, midostaurin and arsenic trioxide via the NHS.
Brentuximab vedotin and arsenic trioxide are both PBS funded here.
The above article was sent to subscribers in Pharmacy Daily's issue from 08 May 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 08 May 18